Skip to content

Evaluation of Cognitive Performance in 4 Dairy Beverages

Evaluation of Cognitive Performance in 4 Dairy Beverages

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05245188
Acronym
COG
Enrollment
20
Registered
2022-02-17
Start date
2022-01-31
Completion date
2022-06-01
Last updated
2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Performance

Brief summary

The objective of the study is to evaluate the cognitive performance of 4 chocolate milk drinks.

Detailed description

Subjects will make a total of 4 visits. Four visits in which they will drink a chocolate milkshake at each visit. At each visit the subjects will have to come fasting, and they will have to perform the cognitive test at the time when they have their peak glycemic level.

Interventions

OTHERChocolate milk shakes - Product 1

11.3 glucose

OTHERChocolate milk shakes - Product 2

8.84 glucose

OTHERChocolate milk shakes - Product 3

4.24 glucose

OTHERChocolate milk shakes - Product 4

4.36 glucose

Sponsors

Universidad Católica San Antonio de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects of both sexes (10 men and 10 women). * Subjects aged between 20 and 35 years. * Subjects with a body mass index between 20 and 25 kg/m2.

Exclusion criteria

* Subjects suffering from diabetes mellitus or any chronic disease. * Subjects with medical problems or a diagnosed psychiatric disorder. * Subjects with alcohol abuse or excessive alcohol consumption (\>3 glasses of wine or beer/day). * Subjects consuming any pharmacological medication that may affect memory. * Participation in another clinical trial in the three months prior to the study. * Unwillingness or inability to comply with clinical trial procedures. * Subjects whose condition does not make them eligible for the study according to the investigator's criteria. * Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frameDescription
Cognitive performanceThe test was carried out half an hour after consumption of the product, except for product 4, which was carried out 15 minutes after consumption.COMPASS cognitive test panel

Secondary

MeasureTime frameDescription
Depression, Anxiety and StressThe test was carried out half an hour after consumption of the product, except for product 4, which was carried out 15 minutes after consumption.DASS21 test
Sleep qualityThe test was carried out half an hour after consumption of the product, except for product 4, which was carried out 15 minutes after consumption.Pittsburgh test

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026